PharmaTimes | in-depth news, features and insights for the ...
2 days ago · Line of duty. Oct 24, 2024. Multiple uses for brands are changing pharma’s data needs.
News - PharmaTimes
2 days ago · NICE recommends remote monitoring technology for heart failure patients. 31st Oct 2024. Heart failure accounted for approximately 90,000 hospital admissions in England in 2019 to 2020.
Microbiotica begins human trials for ulcerative colitis treatment
1 day ago · Microbiotica, a clinical-stage biopharma company, has announced the dosing of the first patient in its Phase 1b First-in-Human trial, COMPOSER-1, for MB310 in ulcerative colitis (UC) patients. This international trial aims to recruit up to 30 adult patients across the UK, Austria, Bulgaria, Poland, and Spain.
Pharmaceuticals in 2022 - PharmaTimes
Dec 7, 2021 · Published in PharmaTimes magazine - December 2021. The pharma industry has been pivotal during the pandemic and this focus looks set to continue into 2022. The coronavirus pandemic has not only boosted many pharmaceutical companies’ revenues, it has also bolstered their reputations. The value of pharma innovation is undoubted, after COVID-19 ...
The ecosystem overtakes the producers in pharma and life sciences
Dec 7, 2021 · Overview. This year has seen a resurgence in M&A activity in the pharma and life sciences sector after a rather anaemic entrance into the decade in 2020.
Is pharma passing the test on access to medicine?
Jan 27, 2021 · The current COVID-19 pandemic is a litmus test of the resilience of health systems and of the pharmaceutical industry’s ability to address issues of access, affordability and sustained supply of medicines, diagnostics and vaccines.
The ever-increasing importance of the patient’s voice
Dec 7, 2021 · We need the patient voice to be heard, to gain the insights that will help direct drug development to reach the true needs of the patients – to help their journey and experience, and, hopefully, their outcomes. This could have important implications for concordance, healthcare professionals’ (HCP) resources and waste – relieving care and ...
PharmaTimes - June 2024
This issue is about the shaping, delivery and future of clinical trials – the exciting dawn of a new era for how therapies reach the marketplace. We cover the influence of digital, the radical shift in trial design and, above all, the need to incorporate patients at every stage. We’ve also got a review of our International Clinical Researcher of the Year bash – an unforgettable 25th ...
PharmaTimes - June 2021
This month’s PharmaTimes is packed with a variety of features centred on clinical research, the lifeblood of our industry. Our insightful front cover article delves into the key regulatory considerations on both sides of the Atlantic for starting cell and gene therapy trials (p26), while others look at the rise of genetic sequencing (p30) and 2021 trends in global trials (p20).
Movers and shakers - PharmaTimes
M&A volumes more than doubled between 2005 and 2019. By comparison, 2020 has been a slow year, with a marked decline in deal activity and a sharp drop in overall deal value. Mega deals have been sparse – last year opened with Bristol-Myers Squibb (BMS) announcing its $74 billion acquisition of Celgene, and Abbvie’s $63 billion bid for ...